Jindi Ma

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Jindi Ma, Xuefang Liu, Yumeng Wei, Ruilong Lu, Kexin Xu, Yan-Ge Tian, Jian-Sheng Li
Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK Pathway. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Jindi Ma, Xuefang Liu, Yumeng Wei, Ruilong Lu, Kexin Xu, Yan-Ge Tian, Jian-Sheng Li
Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK Pathway. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)